Met Life Investment Management, LLC Krystal Biotech, Inc. Transaction History

Met Life Investment Management, LLC

  • $18 Billion
  • Q4 2024

A detailed history of Met Life Investment Management, LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 14,997 shares of KRYS stock, worth $2.81 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,997
Previous 14,317 4.75%
Holding current value
$2.81 Million
Previous $2.6 Million 9.76%
% of portfolio
0.01%
Previous 0.02%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$156.64 - $199.61 $106,515 - $135,734
680 Added 4.75%
14,997 $2.35 Million
Q2 2024

Aug 13, 2024
BUY
$153.12 - $183.64 $491,974 - $590,035
3,213 Added 28.94%
14,317 $2.63 Million
Q1 2024

May 14, 2024
BUY
$108.01 - $179.35 $1.2 Million - $1.99 Million
11,104 New
11,104 $1.98 Million
Q3 2023

May 09, 2024
BUY
$108.51 - $130.22 $20,616 - $24,741
190 Added 1.7%
11,371 $1.32 Million
Q2 2023

Apr 29, 2024
BUY
$78.48 - $130.32 $892,396 - $1.48 Million
11,371 New
11,371 $1.33 Million
Q2 2023

Aug 10, 2023
BUY
$78.48 - $130.32 $14,911 - $24,760
190 Added 1.7%
11,371 $1.33 Million
Q1 2023

May 09, 2024
BUY
$72.39 - $84.27 $809,392 - $942,222
11,181 New
11,181 $895 Million
Q3 2022

May 10, 2024
BUY
$64.85 - $82.4 $59,337 - $75,396
915 Added 8.91%
11,181 $779,000
Q3 2022

Mar 22, 2023
BUY
$64.85 - $82.4 $59,337 - $75,396
915 Added 8.91%
11,181 $779,000
Q3 2022

Nov 14, 2022
BUY
$64.85 - $82.4 $59,337 - $75,396
915 Added 8.91%
11,181 $779,000
Q2 2022

Jun 20, 2023
SELL
$48.93 - $73.47 $44,770 - $67,225
-915 Reduced 8.18%
10,266 $674,000
Q1 2022

May 10, 2024
BUY
$51.99 - $72.11 $533,729 - $740,281
10,266 New
10,266 $683,000
Q1 2022

Jun 20, 2023
SELL
$51.99 - $72.11 $47,570 - $65,980
-915 Reduced 8.18%
10,266 $683,000
Q1 2022

Mar 22, 2023
BUY
$51.99 - $72.11 $188,099 - $260,893
3,618 Added 54.42%
10,266 $683,000
Q1 2022

May 12, 2022
BUY
$51.99 - $72.11 $188,099 - $260,893
3,618 Added 54.42%
10,266 $683,000
Q4 2021

Jun 21, 2023
SELL
$39.81 - $88.24 $180,458 - $399,991
-4,533 Reduced 40.54%
6,648 $465,000
Q3 2021

Jun 21, 2023
SELL
$52.01 - $71.77 $235,761 - $325,333
-4,533 Reduced 40.54%
6,648 $347,000
Q2 2021

May 17, 2024
BUY
$62.14 - $81.82 $63,072 - $83,047
1,015 Added 18.02%
6,648 $452,000
Q2 2021

Jun 21, 2023
SELL
$62.14 - $81.82 $281,680 - $370,890
-4,533 Reduced 40.54%
6,648 $452,000
Q2 2021

Mar 22, 2023
BUY
$62.14 - $81.82 $63,072 - $83,047
1,015 Added 18.02%
6,648 $452,000
Q2 2021

Aug 16, 2021
BUY
$62.14 - $81.82 $63,072 - $83,047
1,015 Added 18.02%
6,648 $452,000
Q1 2021

May 17, 2024
SELL
$59.42 - $85.46 $325,086 - $467,551
-5,471 Reduced 49.27%
5,633 $433,000
Q1 2021

Jun 26, 2023
SELL
$59.42 - $85.46 $329,662 - $474,132
-5,548 Reduced 49.62%
5,633 $434 Million
Q4 2020

Jun 22, 2023
SELL
$40.64 - $61.38 $225,470 - $340,536
-5,548 Reduced 49.62%
5,633 $337,000
Q3 2020

Jun 26, 2023
SELL
$37.76 - $48.49 $209,492 - $269,022
-5,548 Reduced 49.62%
5,633 $242,000
Q2 2020

May 24, 2024
SELL
$37.03 - $60.0 $202,591 - $328,260
-5,471 Reduced 49.27%
5,633 $233 Million
Q2 2020

Jun 26, 2023
SELL
$37.03 - $60.0 $205,442 - $332,880
-5,548 Reduced 49.62%
5,633 $233,000
Q2 2020

Mar 22, 2023
BUY
$37.03 - $60.0 $41,621 - $67,440
1,124 Added 24.93%
5,633 $233,000
Q2 2020

Aug 14, 2020
BUY
$37.03 - $60.0 $41,621 - $67,440
1,124 Added 24.93%
5,633 $233,000
Q1 2020

Jul 12, 2023
SELL
$35.02 - $65.64 $233,653 - $437,950
-6,672 Reduced 59.67%
4,509 $194,000
Q4 2019

Jul 12, 2023
SELL
$33.17 - $65.23 $221,310 - $435,214
-6,672 Reduced 59.67%
4,509 $249,000
Q3 2019

Jul 12, 2023
SELL
$34.72 - $51.3 $231,651 - $342,273
-6,672 Reduced 59.67%
4,509 $156,000
Q3 2019

Mar 22, 2023
SELL
$34.72 - $51.3 $231,651 - $342,273
-6,672 Reduced 59.67%
4,509 $156,000
Q3 2019

Nov 14, 2019
BUY
$34.72 - $51.3 $156,552 - $231,311
4,509 New
4,509 $157,000
Q2 2019

Jul 12, 2023
SELL
$27.2 - $41.2 $181,478 - $274,886
-6,672 Reduced 59.67%
4,509 $182 Million

Others Institutions Holding KRYS

# of Institutions
300
Shares Held
24.3M
Call Options Held
388K
Put Options Held
233K
View Full List

About Krystal Biotech, Inc.

KRYS Quotes by TradingView
  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $4.8B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email